WILMINGTON, Del., Oct. 3, 2019 /PRNewswire/ -- DuPont (NYSE: DD)
today announced it has signed an agreement to acquire the Memcor®
business including ultrafiltration and membrane biofiltration
technologies from Evoqua Water Technologies Corp. The transaction
is expected to close by the end of 2019, subject to customary
closing conditions and regulatory approvals.
"Our strategic intent for the Water Solutions business is to
have a robust portfolio of technologies so that our talented global
organization can leverage a broad range of solutions to solve our
customers' most pressing challenges," said Marc Doyle, DuPont Chief Executive Officer.
"Recently, we announced the intended acquisition of BASF's
ultrafiltration membrane business. This second announcement
reinforces our commitment to invest in specialty solutions aligned
with high growth, attractive end markets where our continued
innovation and customer relationships add value."
The Evoqua ultrafiltration and membrane biofiltration (MBR)
technologies add to DuPont's leading portfolio of water
purification and separation capabilities including ultrafiltration,
reverse osmosis and ion exchange resins. Together with the intended
acquisition of BASF's ultrafiltration business, which is also
expected to close by the end of 2019 subject to customary closing
conditions and regulatory approvals, DuPont will be even better
positioned to provide the products, technology and geographic
diversification needed to meet current and future customer
demand.
"DuPont and Evoqua have enjoyed a mutually beneficial
long-standing business relationship, and this transaction further
complements both companies' strengths to focus more effectively on
what each does best," said HP Nanda, Global Vice President &
General Manager, DuPont Water Solutions. "The addition of Evoqua's
ultrafiltration portfolio opens DuPont Water Solutions to
additional market spaces including membrane bioreactors, submerged
and pressurized ultrafiltration systems bringing more choice and
opportunity for customers."
"This transaction is an excellent opportunity for Memcor® and
its employees to align with DuPont's strength in membrane
development and material science," said Ron
Keating, CEO of Evoqua. "Evoqua's strategy is to source
components that we can incorporate into innovative products, and
integrated solutions and services, that align with our
strengths. We are confident that the Memcor® product line
will thrive under DuPont's leadership and we look forward to
continuing our decades long relationship with DuPont to bring
integrated membrane-based systems and solutions to the
marketplace."
About DuPont Safety & Construction
DuPont Safety
& Construction is a global leader in delivering innovation for
life's essential needs in water, shelter and safety; enabling its
customers to win through unique capabilities, global scale and
iconic brands, including DuPont™
Corian®, Kevlar®, Nomex®, Tyvek®, GreatStuff™,
Styrofoam™ and Filmtec®. More on DuPont Water
Solutions can be found at https://www.dupont.com/water.
About DuPont
DuPont (NYSE: DD) is a global innovation
leader with technology-based materials, ingredients and solutions
that help transform industries and everyday life. Our employees
apply diverse science and expertise to help customers advance their
best ideas and deliver essential innovations in key markets
including electronics, transportation, construction, water, health
and wellness, food and worker safety. More information can be found
at www.dupont.com.
Cautionary Statement Regarding Forward Looking
Statements
This communication contains "forward-looking
statements" within the meaning of the federal securities laws,
including Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
In this context, forward-looking statements often address expected
future business and financial performance and financial condition,
and often contain words such as "expect," "anticipate," "intend,"
"plan," "believe," "seek," "see," "will," "would," "target," and
similar expressions and variations or negatives of these words.
On April 1, 2019, the company
completed the separation of its materials science business into a
separate and independent public company by way of a pro rata
dividend-in-kind of all the then outstanding stock of Dow
Inc. (the "Dow Distribution"). The company completed the
separation of its agriculture business into a separate and
independent public company on June 1,
2019, by way of a pro rata dividend-in-kind of all the then
outstanding stock of Corteva, Inc. (the "Corteva
Distribution").
Forward-looking statements address matters that are, to varying
degrees, uncertain and subject to risks, uncertainties and
assumptions, many of which that are beyond DuPont's control, that
could cause actual results to differ materially from those
expressed in any forward-looking statements. Forward-looking
statements are not guarantees of future results. Some of the
important factors that could cause DuPont's actual results to
differ materially from those projected in any such forward-looking
statements include, but are not limited to: (i) ability and costs
to achieve all the expected benefits from the Dow Distribution and
the Corteva Distribution (together, the "Distributions"); (ii)
restrictions under intellectual property cross license agreements
entered into in connection with the Distributions; (iii)
non-compete restrictions agreed in connection with the
Distributions; (iv) the incurrence of significant costs in
connection with the Distributions, including costs to service debt
incurred by the Company to establish the relative credit profiles
of Corteva, Dow and DuPont and increased costs related to supply,
service and other arrangements that, prior to the Dow Distribution,
were between entities under the common control of DuPont; (v) risks
related to indemnification of certain legacy liabilities of E. I.
du Pont de Nemours and Company ("Historical EID") in connection
with the Corteva Distribution; (vi) potential liability arising
from fraudulent conveyance and similar laws in connection with the
Distributions; (vii) failure to effectively manage acquisitions,
divestitures, alliances, joint ventures and other portfolio
changes, including meeting conditions under the Letter Agreement
entered in connection with the Corteva Distribution, related to the
transfer of certain levels of assets and businesses; (viii)
uncertainty as to the long-term value of DuPont common stock; (ix)
potential inability or reduced access to the capital markets or
increased cost of borrowings, including as a result of a credit
rating downgrade and (x) other risks to DuPont's business,
operations and results of operations including from: failure to
develop and market new products and optimally manage product life
cycles; ability, cost and impact on business operations, including
the supply chain, of responding to changes in market acceptance,
rules, regulations and policies and failure to respond to such
changes; outcome of significant litigation, environmental matters
and other commitments and contingencies; failure to appropriately
manage process safety and product stewardship issues; global
economic and capital market conditions, including the continued
availability of capital and financing, as well as inflation,
interest and currency exchange rates; changes in political
conditions, including tariffs, trade disputes and retaliatory
actions; impairment of goodwill or intangible assets; the
availability of and fluctuations in the cost of energy and raw
materials; business or supply disruption, including in connection
with the Distributions; security threats, such as acts of sabotage,
terrorism or war, natural disasters and weather events and patterns
which could result in a significant operational event for DuPont,
adversely impact demand or production; ability to discover, develop
and protect new technologies and to protect and enforce DuPont's
intellectual property rights; unpredictability and severity of
catastrophic events, including, but not limited to, acts of
terrorism or outbreak of war or hostilities, as well as
management's response to any of the aforementioned factors. These
risks are and will be more fully discussed in DuPont's current,
quarterly and annual reports and other filings made with the U.S.
Securities and Exchange Commission, in each case, as may be amended
from time to time in future filings with the SEC. While the list of
factors presented here is considered representative, no such list
should be considered a complete statement of all potential risks
and uncertainties. Unlisted factors may present significant
additional obstacles to the realization of forward-looking
statements. Consequences of material differences in results as
compared with those anticipated in the forward-looking statements
could include, among other things, business disruption, operational
problems, financial loss, legal liability to third parties and
similar risks, any of which could have a material adverse effect on
DuPont's consolidated financial condition, results of operations,
credit rating or liquidity. You should not place undue reliance on
forward-looking statements, which speak only as of the date they
are made. DuPont assumes no obligation to publicly provide
revisions or updates to any forward-looking statements whether as a
result of new information, future developments or otherwise, should
circumstances change, except as otherwise required by securities
and other applicable laws. A detailed discussion of some of the
significant risks and uncertainties which may cause results and
events to differ materially from such forward-looking statements is
included in the section titled "Risk Factors" (Part II, Item 1A) of
DuPont's Quarterly Report on Form 10-Q filed on August 6, 2019 as may be modified by DuPont's
subsequent quarterly reports on Form 10-Q and current reports on
Form 8-K.
DuPont™, the DuPont Oval Logo, and all trademarks and service
marks denoted with ™, ℠ or ® are owned by affiliates of DuPont
de Nemours, Inc. unless otherwise noted.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/dupont-to-acquire-membrane-business-from-evoqua-water-technologies-corp-300930311.html
SOURCE DuPont